Home LiteratureArticle Details

PMID: 7356521 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.

Cancer research ·Vol. 40 ·No. 2 ·1980-02-00 ·Pages 387-94

DuVernay VH, Pachter JA, Crooke ST

Abstract

暂无摘要

MeSH Terms

Animals Carubicin/analogs & derivatives,pharmacology Cells, Cultured DNA/metabolism DNA, Neoplasm/biosynthesis DNA, Superhelical/metabolism Daunorubicin/analogs & derivatives Doxorubicin/pharmacology Leukemia L1210/drug therapy Liver Neoplasms, Experimental/drug therapy,metabolism Mice RNA, Neoplasm/biosynthesis Rats Structure-Activity Relationship

Chemicals

DNA, Neoplasm DNA, Superhelical RNA, Neoplasm Doxorubicin DNA Carubicin Daunorubicin

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

DuVernay V H

Pachter J A

Crooke S T

Article Info

Journal

Cancer research

Abbr.

Cancer Res

ISSN

0008-5472

Published

1980-02-00

Pages

387-94

Language

English

Region

United States

NLM ID

2984705R

Subset

External Links

PubMed source View journal details

Analysis Services

Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.

Contact

WeChat Official Account